Annuncio pubblicitario
Italia markets open in 2 hours 48 minutes
  • Dow Jones

    37.903,29
    +87,37 (+0,23%)
     
  • Nasdaq

    15.605,48
    -52,34 (-0,33%)
     
  • Nikkei 225

    38.269,50
    -4,55 (-0,01%)
     
  • EUR/USD

    1,0719
    +0,0001 (+0,01%)
     
  • Bitcoin EUR

    53.592,74
    -2.557,36 (-4,55%)
     
  • CMC Crypto 200

    1.261,62
    -77,44 (-5,78%)
     
  • HANG SENG

    18.148,23
    +385,20 (+2,17%)
     
  • S&P 500

    5.018,39
    -17,30 (-0,34%)
     

MIMEDX to Present at Upcoming Investor Conferences

MiMedx Group, Inc
MiMedx Group, Inc

MARIETTA, Ga., Sept. 05, 2023 (GLOBE NEWSWIRE) -- MiMedx Group, Inc. (Nasdaq: MDXG) (“MIMEDX” or the “Company”) today announced that senior management will participate in the following investor conferences:

H.C. Wainwright 25th Annual Global Investment Conference
Presentation: Tuesday, September 12, 2023 at 12:30 PM ET
Webcast: Click here to access

Northland Capital Markets Institutional Investor Conference (Virtual)
Participation: Tuesday, September 19, 2023

Cantor Fitzgerald Global Healthcare Conference 2023
Presentation: Wednesday, September 27, 2023 at 10:55 AM ET
Webcast: Click here to access

ANNUNCIO PUBBLICITARIO

Institutional investors interested in meeting with senior management may contact their respective H.C. Wainwright, Northland Capital, or Cantor Fitzgerald representative.

A live webcast of each presentation will be available on the Events page of the Investors section of the Company’s website at www.mimedx.com or through the conference site by using the links above. A replay will be available on the Company’s website following the event.

About MIMEDX
MIMEDX is a pioneer and leader focused on helping humans heal. With more than a decade of helping clinicians manage chronic and other hard-to-heal wounds, MIMEDX is dedicated to providing a leading portfolio of products for applications in the wound care, burn, and surgical sectors of healthcare. The Company’s vision is to be the leading global provider of healing solutions through relentless innovation to restore quality of life. For additional information, please visit www.mimedx.com.

Contact:
Matt Notarianni
Investor Relations
470-304-7291
mnotarianni@mimedx.com